Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Month: October 2007
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Purdue Pharma Products LP et al. v. Par Pharmaceutical Inc. et al.1:07-cv-00666; filed October 24, 2007 in the District Court of Delaware…
-
By Kevin E. Noonan — Amgen’s recombinant erythropoietin (EPO) franchise (Aranesp® and Epogen®, as well as Johnson & Johnson’s Procrit®) survived another challenge last week, when a jury found that Hoffmann-LaRoche’s pegylated EPO preparation (Mircera®) infringed three Amgen patents: U.S. Patent Nos. 5,547,933 (the ‘933 patent), 5,441,868 (the ‘868 patent), and 5,618,698 (the…
-
By Christopher P. Singer — As reported last Tuesday, October 23, 2007, ARYx Therapeutics set its planned initial public offering at 5 million shares for an estimated price of $14 to $16 each. In the filing, ARYx indicated that Morgan Stanley, CIBC World Markets, Jefferies & Co, and Leerink Swann were underwriting the…
-
November 8, 2007 – Trilateral Cooperation: Successes, Opportunities, and Challenges (Intellectual Property Owners Association) – Washington, D.C. November 13-15, 2007 – Pharma and Biotech Collaborative Agreements (American Conference Institute) – New York, NY*** December 3, 2007 – 18th Annual Conference on U.S. Patent and Trademark Office Law and Practice – PTO Day (Intellectual Property Owners…
-
By Kevin E. Noonan — The Subcommittee on Court, the Internet and Intellectual Property of the House of Representative’s Judiciary Committee has scheduled a hearing entitled "Stifling or Stimulating – The Role of Gene Patents in Research and Genetic Testing" for Tuesday, October 30, 2007. While not stating so on the hearing notice,…
-
The Intellectual Property Owners Association (IPO) will be co-sponsoring a conference entitled: "Trilateral Cooperation: Successes, Opportunities, and Challenges" on November 8, 2007 in Washington, D.C. The conference, which is being held in conjunction with the 25th Annual Meeting of the Trilateral Patent Offices (U.S. Patent and Trademark Office, Japan Patent Office, and European Patent Office),…
-
The Intellectual Property Owners Association (IPO) and U.S. Patent and Trademark Office will be co-sponsoring the 18th Annual Conference on U.S. Patent and Trademark Office Law and Practice (PTO Day) on December 3, 2007 in Washington, D.C. While a program for the conference is not yet available, the IPO has announced that the conference will…
-
By Kevin E. Noonan — Like the most popular kid at a high school dance being the first to take the floor, GlaxoSmithKline’s (GSK) lawsuit against John Dudas and the U.S. Patent and Trademark Office’s new continuation and claims rules entitled "Changes to Practice for Continued Examination Filings, Patent Applications Containing Patentably-indistinct Claims…
-
By Donald Zuhn — Over the past week, Patent Docs has reported on two challenges to new IDS rules proposed by the U.S. Patent and Trademark Office ("Changes to Information Disclosure Statement Requirements and Other Related Matters," 71 Fed. Reg. 38,808). The USPTO’s new IDS rules would require applicants to, inter alia, provide…
-
By Suresh Pillai — Epigenomics AG of Frankfurt, Germany has been awarded U.S. Patent No. 7,229,759 ("Highly sensitive method for the detection of cytosine methylation patterns," issued June 12, 2007). The ‘759 patent, covering a method for the detection of cytosine methylation in genomic DNA samples, is the fourteenth U.S. patent to be…
Patent Docs 